Real People, Real Stories:

To better understand the experience of those living with eye mites, we spoke to one optometrist and two people who have had ...
The American Journal of Managed Care

Outlook on the Future of Demodex Blepharitis Treatment

Dr Shamie shares her optimism in the advancement of Demodex Blepharitis treatment. This is a video synopsis/summary of an Insights involving Neda Shamie, MD. With an FDA-approved treatment now ...
The American Journal of Managed Care

Other Clinical Considerations in Demodex Blepharitis Treatment

Eric D. Donnenfeld, MD; underscores the significance of an FDA approved treatment for Demodex blepharitis as well as past alternative treatments. This is a video synopsis/summary of an Insights ...
Ophthalmology Times

Inside the ASCRS preoperative ocular surface disease algorithm: Key updates

As expectations for refractive cataract surgery continue to rise, preoperative ocular surface optimization remains essential ...
Action Reporter Media

FDA-Approved Drop XDEMVY Offers Targeted Relief for Demodex Blepharitis Patients, Modern Vision Solutions Reports

Modern Vision Solutions has announced the publication of a new article, “Demodex Blepharitis Treatment in Omaha,” highlighting a significant shift in how optometrists approach the treatment of chronic ...
Nasdaq

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

IRVINE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that a $15 million milestone payment due Tarsus has been achieved following regulatory ...